Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.

Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.

Neurofibromatosis type 1 (NF1) is the most common tumor predisposition disorder affecting 1/3500 worldwide. Patients are at risk of developing benign (neurofibromas) and malignant peripheral nerve sheath tumors (MPNST). The AXL receptor tyrosine kinase has been implicated in several kinds of cancers...

Full description

Bibliographic Details
Main Authors: Gunnar Johansson, Po-Chun Peng, Po-Yuan Huang, Hsiung-Fei Chien, Kuo-Tai Hua, Min-Liang Kuo, Chin-Tin Chen, Ming-Jen Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4281253?pdf=render

Internet

http://europepmc.org/articles/PMC4281253?pdf=render

Similar Items